US EditionResearch: SMPDL3B a Novel Biomarker and Therapeutic Target in ME - The ME Association
Summary by ME Association
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Published on: 09.07.2025 05:06Author: Martin RückerThe nephrologist Georg Schlieper warns against dangerous apheresis offers, but also sees approaches for meaningful therapies. What patients: leave their fingers behind and what they should pay attention to, he explains in the RiffReporter interview.
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
